HEADER ANTIBIOTIC 24-OCT-05 2ERI TITLE SOLUTION STRUCTURE OF CIRCULIN B COMPND MOL_ID: 1; COMPND 2 MOLECULE: CIRCULIN B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CIRB; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CHASSALIA PARVIFLORA; SOURCE 3 ORGANISM_TAXID: 58431; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CYSTINE KNOT, BETA HAIRPIN, BETA TURN, ANTIBIOTIC EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR D.J.CRAIK,N.L.DALY REVDAT 3 09-MAR-22 2ERI 1 REMARK LINK REVDAT 2 24-FEB-09 2ERI 1 VERSN REVDAT 1 15-NOV-05 2ERI 0 JRNL AUTH A.KOLTAY,N.L.DALY,K.R.GUSTAFSON,D.J.CRAIK JRNL TITL STRUCTURE OF CIRCULLIN B AND IMPLICATIONS FOR ANTIMICROBIAL JRNL TITL 2 ACTIVITY OF THE CYCLOTIDES JRNL REF INT.J.PEPT.PROTEIN RES. V. 11 99 2005 JRNL REFN ISSN 0367-8377 JRNL DOI 10.1007/S10989-004-1722-2 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CNS 1.1 REMARK 3 AUTHORS : BRUKER (XWINNMR), REMARK 3 BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI, REMARK 3 NILGES, PANNU,READ,RICE,SIMONSON,WARREN (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ERI COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000035006. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 295 REMARK 210 PH : 3.5 REMARK 210 IONIC STRENGTH : 1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1MM CIRCULIN B PH 3.5; 70% H2O, REMARK 210 20% CD3CN, 10% D2 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY; DQF-COSY; E REMARK 210 -COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : ARX; DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XEASY 1.3.7, DYANA 1.5, CNS 1.1 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 12 40.19 -82.40 REMARK 500 1 VAL A 29 34.88 -140.44 REMARK 500 2 SER A 12 44.33 -76.83 REMARK 500 2 LYS A 22 -16.52 80.73 REMARK 500 2 VAL A 29 37.73 -142.78 REMARK 500 3 SER A 12 38.02 -77.70 REMARK 500 4 SER A 12 44.12 -78.54 REMARK 500 4 LYS A 22 -3.94 73.88 REMARK 500 4 VAL A 29 38.11 -146.35 REMARK 500 5 SER A 12 38.15 -78.29 REMARK 500 5 LYS A 22 -19.57 82.35 REMARK 500 5 VAL A 29 41.38 -141.09 REMARK 500 6 SER A 12 42.76 -75.70 REMARK 500 6 LYS A 22 -20.28 81.75 REMARK 500 6 VAL A 29 38.72 -141.13 REMARK 500 7 SER A 12 41.89 -76.18 REMARK 500 7 LYS A 22 -6.65 74.45 REMARK 500 7 VAL A 29 37.30 -143.28 REMARK 500 8 SER A 12 40.69 -77.87 REMARK 500 8 LYS A 22 -19.63 80.22 REMARK 500 8 VAL A 29 41.16 -143.08 REMARK 500 9 SER A 12 40.84 -80.75 REMARK 500 10 SER A 12 41.49 -77.17 REMARK 500 10 LYS A 22 -17.05 77.15 REMARK 500 10 VAL A 29 39.25 -150.99 REMARK 500 11 SER A 12 40.02 -83.20 REMARK 500 11 LYS A 22 -17.58 79.31 REMARK 500 12 SER A 12 40.64 -76.63 REMARK 500 12 LYS A 22 -15.99 77.45 REMARK 500 13 SER A 12 39.14 -81.03 REMARK 500 14 SER A 12 30.92 -77.31 REMARK 500 14 VAL A 29 38.19 -140.47 REMARK 500 15 SER A 12 40.83 -82.39 REMARK 500 15 LYS A 22 -10.38 78.31 REMARK 500 15 VAL A 29 38.39 -145.62 REMARK 500 16 SER A 12 40.48 -75.95 REMARK 500 17 SER A 12 43.29 -81.07 REMARK 500 17 VAL A 29 37.36 -150.58 REMARK 500 18 SER A 12 39.11 -76.24 REMARK 500 18 VAL A 29 36.85 -150.23 REMARK 500 19 SER A 12 41.24 -79.24 REMARK 500 19 CYS A 19 84.96 -69.35 REMARK 500 19 LYS A 22 -10.99 82.29 REMARK 500 19 VAL A 29 33.59 -143.12 REMARK 500 20 SER A 12 35.87 -79.32 REMARK 500 REMARK 500 REMARK: NULL DBREF 2ERI A 1 27 UNP P56879 CIRB_CHAPA 5 31 DBREF 2ERI A 28 31 UNP P56879 CIRB_CHAPA 1 4 SEQRES 1 A 31 CYS GLY GLU SER CYS VAL PHE ILE PRO CYS ILE SER THR SEQRES 2 A 31 LEU LEU GLY CYS SER CYS LYS ASN LYS VAL CYS TYR ARG SEQRES 3 A 31 ASN GLY VAL ILE PRO SHEET 1 A 3 GLU A 3 SER A 4 0 SHEET 2 A 3 VAL A 23 TYR A 25 -1 O CYS A 24 N GLU A 3 SHEET 3 A 3 SER A 18 LYS A 20 -1 N LYS A 20 O VAL A 23 SSBOND 1 CYS A 1 CYS A 17 1555 1555 2.03 SSBOND 2 CYS A 5 CYS A 19 1555 1555 2.03 SSBOND 3 CYS A 10 CYS A 24 1555 1555 2.03 LINK N CYS A 1 C PRO A 31 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1